DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS 6201
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A2b receptor antagonist
GS 6201
×
Maximum Phase:
1
First Approval:
None
UNII:
67CKV7X08G
Molecule Type:
Small molecule
Molecular Formula:
C21H21F3N6O2
Molecular Weight:
446.43
AlogP:
3.25
PSA:
90.5
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MIRODENAFIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIRODENAFIL
×
Maximum Phase:
1
First Approval:
None
UNII:
504G362H0H
Molecule Type:
Small molecule
Molecular Formula:
C26H37N5O5S
Molecular Weight:
531.68
AlogP:
2.45
PSA:
120.76
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PERTECHNETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PERTECHNETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
HO4Tc
Molecular Weight:
163.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
USL-311
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
USL-311
×
Maximum Phase:
1
First Approval:
None
UNII:
2BTG5MX2Q2
Molecule Type:
Small molecule
Molecular Formula:
C24H34N6O
Molecular Weight:
422.58
AlogP:
3.11
PSA:
64.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ITX-5061
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Pemphigus
MAP kinase p38 alpha inhibitor
ITX-5061
×
Maximum Phase:
1
First Approval:
None
UNII:
J4RA8K2Q2A
Molecule Type:
Small molecule
Molecular Formula:
C30H38ClN3O7S
Molecular Weight:
620.17
AlogP:
4.05
PSA:
123.27
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DPOC-4088
1
Small molecule
Investigational
Unknown
Unknown
Venous Thrombosis
Unknown
DPOC-4088
×
Maximum Phase:
1
First Approval:
None
UNII:
S6MPG81Y84
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClF3N6O2
Molecular Weight:
452.82
AlogP:
2.35
PSA:
101.8
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
E-7130
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E-7130
×
Maximum Phase:
1
First Approval:
None
UNII:
R6WE4X56YH
Molecule Type:
Small molecule
Molecular Formula:
C58H83NO17
Molecular Weight:
1066.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
METHYL P-TOLUENESULFONYL-L-ARGININATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYL P-TOLUENESULFONYL-L-ARGININATE
×
Maximum Phase:
1
First Approval:
None
UNII:
1H7BKF44U1
Molecule Type:
Small molecule
Molecular Formula:
C14H22N4O4S
Molecular Weight:
342.42
AlogP:
-0.13
PSA:
136.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SAD448
1
Small molecule
Investigational
Unknown
Unknown
Ocular Hypertension
Cannabinoid CB1 receptor agonist
SAD448
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O8S
Molecular Weight:
532.58
AlogP:
1.31
PSA:
165.92
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PIPERAQUINE TETRAPHOSPHATE
1
Small molecule
Investigational
Unknown
Unknown
Malaria, Vivax
Unknown
PIPERAQUINE TETRAPHOSPHATE
×
Maximum Phase:
1
First Approval:
None
UNII:
IHB5WLO51Q
Molecule Type:
Small molecule
Molecular Formula:
C29H44Cl2N6O16P4
Molecular Weight:
927.5
AlogP:
5.42
PSA:
38.74
HBD:
0.0
HBA:
#RotB:
6.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TIGULIXOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TIGULIXOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
CYCLOHEXANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYCLOHEXANE
×
Maximum Phase:
1
First Approval:
None
UNII:
48K5MKG32S
Molecule Type:
Small molecule
Molecular Formula:
C6H12
Molecular Weight:
84.16
AlogP:
2.34
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
283FTA936D
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BMS-779788
1
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis
LXR-beta agonist
BMS-779788
×
Maximum Phase:
1
First Approval:
None
UNII:
FB7ZTJ8M8A
Molecule Type:
Small molecule
Molecular Formula:
C28H29ClN2O3S
Molecular Weight:
509.07
AlogP:
6.15
PSA:
72.19
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MILCICLIB MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
MILCICLIB MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
82W826FL6S
Molecule Type:
Small molecule
Molecular Formula:
C29H36N8O5
Molecular Weight:
576.66
AlogP:
2.57
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
SAY8KVM4HU
Molecule Type:
Small molecule
Molecular Formula:
C23H15ClF2N4O3
Molecular Weight:
468.85
AlogP:
5.0
PSA:
110.1
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LY-3200882
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3200882
×
Maximum Phase:
1
First Approval:
None
UNII:
19HY34R6UN
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.67
PSA:
94.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
JNJ-38877605
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
JNJ-38877605
×
Maximum Phase:
1
First Approval:
None
UNII:
15UDG410PN
Molecule Type:
Small molecule
Molecular Formula:
C19H13F2N7
Molecular Weight:
377.36
AlogP:
3.21
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PF-05105679
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
PF-05105679
×
Maximum Phase:
1
First Approval:
None
UNII:
F2B10OFV7Y
Molecule Type:
Small molecule
Molecular Formula:
C26H21FN2O3
Molecular Weight:
428.46
AlogP:
5.48
PSA:
70.5
HBD:
1.0
HBA:
#RotB:
6.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
75
76
77
78
79
80
81
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA